Koninklijke Philips Revenue 2010-2024 | PHG

Koninklijke Philips annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Koninklijke Philips revenue for the quarter ending September 30, 2024 was $4.813B, a 8.27% increase year-over-year.
  • Koninklijke Philips revenue for the twelve months ending September 30, 2024 was $18.965B, a 3.39% decline year-over-year.
  • Koninklijke Philips annual revenue for 2023 was $19.664B, a 4.69% increase from 2022.
  • Koninklijke Philips annual revenue for 2022 was $18.783B, a 7.46% decline from 2021.
  • Koninklijke Philips annual revenue for 2021 was $20.297B, a 9.04% decline from 2020.
Koninklijke Philips Annual Revenue
(Millions of US $)
2023 $19,664
2022 $18,783
2021 $20,297
2020 $22,315
2019 $21,820
2018 $21,401
2017 $20,097
2016 $27,129
2015 $26,921
2014 $28,435
2013 $30,988
2012 $31,880
2011 $31,448
2010 $33,756
2009 $32,339
Koninklijke Philips Quarterly Revenue
(Millions of US $)
2024-09-30 $4,813
2024-06-30 $4,805
2023-06-30 $4,874
2023-03-31 $4,473
2022-06-30 $4,445
2021-06-30 $5,097
2020-06-30 $4,839
2019-06-30 $5,250
2018-06-30 $5,114
2017-06-30 $4,724
2016-12-31 $7,842
2016-09-30 $6,579
2016-06-30 $6,622
2016-03-31 $6,086
2015-12-31 $7,793
2015-09-30 $6,493
2015-06-30 $6,608
2015-03-31 $6,026
2014-12-31 $6,934
2014-09-30 $7,360
2014-06-30 $7,261
2014-03-31 $6,880
2013-12-31 $9,217
2013-09-30 $7,442
2013-06-30 $7,384
2013-03-31 $6,945
2012-12-31 $9,640
2012-09-30 $7,995
2012-06-30 $7,188
2012-03-31 $7,364
2011-12-31 $8,799
2011-09-30 $7,447
2011-06-30 $7,502
2011-03-31 $7,583
2010-12-31 $10,061
2010-09-30 $7,945
2010-06-30 $7,900
2010-03-31 $7,868
2009-12-31 $10,727
2009-09-30 $8,108
2009-06-30 $7,441
2009-03-31 $6,638
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.642B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $221.767B 27.38
Boston Scientific (BSX) United States $151.377B 43.52
Stryker (SYK) United States $149.082B 32.08
EssilorLuxottica (ESLOY) France $125.055B 0.00
Medtronic (MDT) Ireland $117.214B 17.41
Lonza Group Ag (LZAGY) Switzerland $45.950B 0.00
Haleon (HLN) United Kingdom $43.139B 28.03
GE HealthCare Technologies (GEHC) United States $40.136B 20.82
ResMed (RMD) United States $37.119B 30.50
Terumo (TRUMY) Japan $28.886B 41.07
Zimmer Biomet Holdings (ZBH) United States $22.107B 14.07
Insulet (PODD) United States $19.438B 77.40
Baxter (BAX) United States $16.737B 10.89
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.084B 40.57
Sunny Optical Technology (SNPTF) China $9.976B 0.00
Bio-Rad Laboratories (BIO) United States $9.966B 33.87
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.433B 14.95
ICU Medical (ICUI) United States $4.121B 39.23
Prestige Consumer Healthcare (PBH) United States $3.893B 19.36
Envista Holdings (NVST) United States $3.678B 27.40
Haemonetics (HAE) United States $3.430B 16.74
Perrigo (PRGO) Ireland $3.366B 9.91
GN Store Nord (GNNDY) Denmark $3.027B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.927B 18.84
Neogen (NEOG) United States $2.495B 28.75
LeMaitre Vascular (LMAT) United States $2.247B 54.60
AtriCure (ATRC) United States $2.067B 0.00
Green Thumb Industries (GTBIF) United States $1.464B 25.63
InMode (INMD) Israel $1.462B 8.79
AdaptHealth (AHCO) United States $1.430B 10.22
BioLife Solutions (BLFS) United States $1.313B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.270B 0.00
Owens & Minor (OMI) United States $1.150B 8.99
Evolus (EOLS) United States $0.922B 0.00
Phibro Animal Health (PAHC) United States $0.887B 15.64
CeriBell (CBLL) United States $0.833B 0.00
Curaleaf Holdings (CURLF) Canada $0.830B 0.00
Capricor Therapeutics (CAPR) United States $0.649B 0.00
VAREX IMAGING (VREX) United States $0.561B 24.73
Surmodics (SRDX) United States $0.511B 0.00
Omeros (OMER) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
Verano Holdings (VRNOF) United States $0.429B 0.00
Valneva SE (VALN) France $0.412B 0.00
ZimVie (ZIMV) United States $0.401B 33.77
Quanterix (QTRX) United States $0.370B 0.00
Cerus (CERS) United States $0.360B 0.00
Viemed Healthcare (VMD) United States $0.322B 30.67
Sanara MedTech (SMTI) United States $0.317B 0.00
Biote (BTMD) United States $0.309B 6.76
OraSure Technologies (OSUR) United States $0.291B 19.50
Canopy Growth (CGC) Canada $0.265B 0.00
Zynex (ZYXI) United States $0.263B 55.13
High Tide (HITI) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.233B 3.28
Utah Medical Products (UTMD) United States $0.208B 15.52
Aurora Cannabis (ACB) Canada $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 104.70
MacroGenics (MGNX) United States $0.190B 0.00
Organigram Holdings (OGI) Canada $0.189B 0.00
TerrAscend (TSNDF) Canada $0.154B 0.00
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 18.27
Quipt Home Medical (QIPT) United States $0.135B 0.00
Jin Medical (ZJYL) China $0.125B 0.00
Fonar (FONR) United States $0.102B 11.54
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.089B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.072B 0.00
INLIF (INLF) $0.071B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Apyx Medical (APYX) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
United-Guardian (UG) United States $0.050B 14.35
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00